---
title: "Global Full-body CT Market Report 2025 - Market Size, Share, Price, Trend and Forecast"
datePublished: Thu Oct 09 2025 17:28:26 GMT+0000 (Coordinated Universal Time)
cuid: cmgjoyj2z000102l14xnmchgk
slug: global-full-body-ct-market-report-2025-market-size-share-price-trend-and-forecast

---

# Global Full-body CT Market Report 2025 - Market Size, Share, Price, Trend and Forecast

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global full-body CT market size was valued at USD 2.84 billion in 2024. The market is projected to grow from USD 3.12 billion in 2025 to USD 5.67 billion by 2032, exhibiting a CAGR of 7.8% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/124032/global-fullbody-ct-market">
            https://www.24chemicalresearch.com/download-sample/124032/global-fullbody-ct-market</a></b></div><br><p>
</p><p>Full-body CT scanners are advanced medical imaging systems that provide comprehensive anatomical visualization through cross-sectional X-ray imaging. These systems combine rotating X-ray tubes with detector arrays to create detailed 3D reconstructions of internal structures, enabling diagnosis across multiple clinical applications including oncology, cardiology, and trauma assessment. Modern iterations incorporate dose-reduction algorithms and AI-powered image reconstruction to enhance safety and diagnostic accuracy.</p><p>
</p><p>The market growth is being driven by increasing cancer screening programs, rising demand for early disease detection, and technological advancements in low-dose imaging. However, concerns about radiation exposure and high equipment costs remain key challenges. Major manufacturers are addressing these issues through innovations like spectral CT and photon-counting detectors, with recent product launches such as Siemens Healthineers' NAEOTOM Alpha receiving FDA clearance in 2023 for its quantum detector technology.</p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Rising Prevalence of Chronic Diseases to Fuel Full-body CT Demand</strong></p><p>
</p><p>The global burden of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions continues to rise significantly, driving adoption of advanced diagnostic imaging solutions. Full-body CT scans play a critical role in early disease detection, treatment planning, and monitoring therapeutic responses. With cancer cases projected to increase by nearly 50% over the next decade, healthcare systems are prioritizing investments in comprehensive diagnostic technologies. The ability of full-body CT to provide detailed cross-sectional images of all major organs makes it indispensable in modern diagnostic workflows.</p><p>
</p><p style="text-align:center"><strong>Technological Advancements in Imaging Systems Accelerate Market Growth</strong></p><p>
</p><p>Recent technological breakthroughs in CT imaging systems are transforming diagnostic capabilities across healthcare settings. Next-generation full-body CT scanners now incorporate artificial intelligence, enhanced resolution detectors, and reduced radiation dose protocols. These innovations improve diagnostic accuracy while addressing patient safety concerns. The market has witnessed the introduction of ultra-high-resolution scanners capable of detecting sub-millimeter abnormalities, significantly improving early disease detection rates. Leading manufacturers are actively developing hybrid systems combining CT with PET and MRI functionalities, creating new opportunities in precision diagnostics.</p><p>
</p><p>The integration of cloud computing and AI-powered image analysis software has further enhanced the clinical utility of full-body CT scans. These systems enable automated lesion detection, quantification, and longitudinal tracking of disease progression with minimal human intervention. Such technological synergies are expected to drive over 60% of new system purchases through 2032.</p><p>

</p><p><strong>â¤ Healthcare facilities are increasingly adopting 512-slice CT systems, with installation rates growing at over 15% annually since 2022, reflecting the shift toward comprehensive, whole-body diagnostic solutions.</strong></p><p>
</p><p>Emerging markets are witnessing rapid infrastructure development, with governments investing heavily in modern medical imaging capabilities. This global expansion of healthcare access presents significant growth potential for full-body CT manufacturers in untapped regions.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>High Capital and Operational Costs Limit Market Penetration</strong></p><p>
</p><p>While full-body CT systems offer unparalleled diagnostic capabilities, their adoption faces significant cost-related barriers. Advanced CT scanners represent substantial capital investments, with high-end models exceeding several million dollars. These costs create procurement challenges for smaller healthcare facilities and hospitals in developing regions. Beyond initial purchase prices, operational expenses including maintenance contracts, technician training, and software upgrades further strain healthcare budgets.</p><p>
</p><p>The total cost of ownership for full-body CT systems has increased by nearly 25% since 2021 due to rising component costs and technology complexity. Many facilities face difficult trade-offs between investing in cutting-edge imaging technology and maintaining essential healthcare services. This financial pressure is particularly acute in public healthcare systems where budgetary constraints limit equipment upgrades.</p><p>
</p><p><strong>Other Critical Restraints</strong></p><p>
</p><p><strong>Radiation Exposure Concerns</strong></p><p>
Patient and physician concerns about cumulative radiation exposure continue affecting full-body CT utilization patterns. Although newer systems incorporate dose-reduction technologies, the perception of risk remains a barrier to more frequent use, especially in pediatric and screening applications.</p><p>
</p><p><strong>Regulatory Compliance Challenges</strong></p><p>
Evolving regulatory requirements for medical imaging equipment create additional complexity for market participants. The certification process for new CT models now typically exceeds 18 months in major markets, delaying technology commercialization and product refresh cycles.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Expansion of Preventive Health Screening Programs Creates New Market Potential</strong></p><p>
</p><p>The growing emphasis on preventive healthcare presents significant opportunities for full-body CT adoption. Corporate wellness programs and executive health check-up packages increasingly incorporate whole-body imaging as a premium service offering. This trend aligns with rising health consciousness among affluent populations willing to pay out-of-pocket for comprehensive diagnostic evaluations. Emerging markets in Asia and the Middle East are demonstrating particular enthusiasm for preventive imaging services, with several countries integrating full-body CT into national health screening initiatives.</p><p>
</p><p>Developments in artificial intelligence are creating new service-based business models for CT imaging. Cloud-based AI analytics platforms enable remote interpretation services and secondary consultations, expanding access to specialized diagnostic expertise. These technological enablers help overcome traditional barriers related to radiologist shortages in underserved regions.</p><p>
</p><p style="text-align:center"><strong>Emerging Applications in Oncology and Neurology Drive Innovation</strong></p><p>
</p><p>Full-body CT is gaining traction in specialized clinical applications, particularly in oncology workflows. The technology plays an increasingly vital role in comprehensive cancer staging, treatment response assessment, and recurrence monitoring. Advanced visualization software now enables automated tumor burden quantification across multiple organ systems, supporting precision medicine approaches in oncology. Similarly, neurology applications are expanding beyond traditional stroke evaluation to include neurodegenerative disease monitoring and neurovascular assessment.</p><p>
</p><p>Manufacturers are responding to these clinical needs with tailored system configurations and dedicated software packages. The development of specialized protocols for emerging applications represents a key growth avenue through 2032, with projected annual growth exceeding 12% in these niche segments.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Workforce Shortages Strain Imaging Service Capacities</strong></p><p>
</p><p>The global shortage of radiologists and trained CT technologists presents a significant challenge for full-body CT adoption. Many healthcare systems face critical staffing gaps that limit their ability to fully utilize existing imaging capacity. The education pipeline for imaging professionals has struggled to keep pace with technology advancements and growing diagnostic demands. This workforce crisis is particularly acute in rural and remote regions, where attracting and retaining skilled personnel remains challenging.</p><p>
</p><p>Training requirements for operating advanced full-body CT systems have become increasingly complex, requiring specialized expertise in both hardware operation and software utilization. The learning curve for new technologists now typically exceeds six months, creating operational bottlenecks during staff transitions. These workforce constraints are expected to persist through the forecast period despite various recruitment and training initiatives.</p><p>
</p><p><strong>Other Pressing Challenges</strong></p><p>
</p><p><strong>Data Management Complexities</strong></p><p>
The exponential growth in imaging data volume creates significant infrastructure challenges. Full-body CT studies generate exceptionally large datasets, with single examinations often exceeding 1,000 images. Storing, processing, and transmitting these datasets requires substantial IT investments that many healthcare providers struggle to maintain.</p><p>
</p><p><strong>Reimbursement Policy Uncertainties</strong></p><p>
Changing healthcare reimbursement landscapes create financial uncertainty for imaging service providers. Several national health systems are reevaluating coverage policies for full-body CT scans, particularly in screening applications where clinical benefits remain debated. These policy reviews may impact equipment purchasing decisions and service accessibility in key markets.</p><p>

<strong>Segment Analysis:</strong>
</p><p>
		
		
			By Application
			
				</p><p>
		
		
			By End User
			
				</p><p>
		
		
			By Technology
			
				</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Market Leaders Leverage Advanced Imaging Technologies for Competitive Edge</strong></p><p>
</p><p>The global full-body CT market is characterized by <strong>strong competition among established medical imaging manufacturers</strong>, with technological innovation being the primary differentiator. <strong>Siemens Healthineers</strong> currently dominates with approximately 28% market share in 2024, driven by its premium SOMATOM line of CT scanners that offer ultra-low radiation doses while maintaining diagnostic accuracy.</p><p>
</p><p><strong>GE Healthcare</strong> follows closely with 25% market penetration, particularly strong in North America where its Revolution CT systems are widely adopted. Meanwhile, <strong>Canon Medical Systems</strong> (formerly Toshiba Medical) has gained significant traction in Asia-Pacific markets with its cost-effective Aquilion solutions, capturing approximately 18% market share.</p><p>
</p><p>The competitive dynamics are intensifying as companies shift focus from hardware specifications to integrated solutions combining AI-assisted diagnostics, workflow optimization, and dose management. In 2024, Philips Healthcare launched its SmartCT platform, integrating AI algorithms that reduced scan times by 30% while improving image reconstruction accuracy - a development that's reshaping competitive expectations.</p><p>
<strong>List of Major Full-Body CT Manufacturers</strong></p><p>
</p><p>Siemens Healthineers (Germany)</p><p>GE Healthcare (U.S.)</p><p>Canon Medical Systems (Japan)</p><p>Philips Healthcare (Netherlands)</p><p>Hitachi Medical Systems (Japan)</p><p>Shimadzu Corporation (Japan)</p><p>Neusoft Medical Systems (China)</p><p>Shenzhen Anke High-Tech (China)</p><p>United Imaging Healthcare (China)</p><p>
</p><p>Several strategic shifts are reshaping the competitive landscape. Siemens and GE are investing heavily in photon-counting CT technology, while Asian manufacturers are gaining ground through competitive pricing and government-backed healthcare initiatives. The emergence of Chinese players like United Imaging, which captured 7% market share in 2024, demonstrates how regional dynamics influence global competition.</p><p>
</p><p>
<strong>GLOBAL FULL-BODY CT MARKET TRENDS</strong></p><p>
<strong>Technological Advancements in Imaging Precision Driving Market Growth</strong></p><p>
</p><p>The global full-body CT market continues to evolve with significant technological innovations enhancing diagnostic accuracy and patient safety. AI-powered image reconstruction has emerged as a key trend, reducing radiation exposure by up to 30% while maintaining diagnostic quality. Recent developments in spectral CT imaging allow simultaneous multi-energy scanning, providing superior tissue characterization. The integration of deep learning algorithms has improved lesion detection rates by approximately 20% across oncology applications, significantly impacting early disease diagnosis and treatment planning.</p><p>
<strong>Other Market Trends</strong></p><p>
</p><p><strong>Rising Demand for Preventive Health Screening</strong></p><p>
</p><p>With increasing health awareness globally, preventive full-body CT scans are gaining traction in corporate wellness programs and high-net-worth individual health assessments. Mobile CT solutions are expanding access, particularly in emerging markets, with portable systems demonstrating growth rates exceeding 15% annually. While concerns about overdiagnosis persist, the demonstrated value in detecting early-stage cancers and cardiovascular conditions continues to drive adoption among proactive patient populations.</p><p>
<strong>Regulatory and Reimbursement Landscape Evolution</strong></p><p>
</p><p>Changing healthcare policies worldwide are significantly influencing market dynamics. Several countries have implemented new CPT coding structures for whole-body CT scans, improving reimbursement scenarios. The FDA's 2023 clearance of ultra-low-dose protocols for screening applications has opened new clinical pathways. However, regional variations in radiation safety regulations continue to pose challenges for multinational equipment manufacturers, requiring tailored product development strategies across different markets.</p><p>
</p><p><strong>The global full-body CT market size was valued at approximately $2.8 billion in 2024, with an anticipated compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.</strong> This growth trajectory reflects both technological adoption curves and expanding clinical indications for comprehensive body imaging.</p><p>
</p><p>Competitive dynamics remain intense among major manufacturers, with ongoing R&amp;D investments focusing on workflow optimization and dose reduction. Recent product launches feature automated patient positioning systems and cloud-based image sharing capabilities, addressing two critical pain points in clinical practice. The market continues to see strategic partnerships between imaging manufacturers and AI software developers, creating integrated solutions that enhance diagnostic confidence while reducing interpretation time.</p><p>

<strong>Regional Analysis: Global Full-body CT Market</strong></p><p>

  
    North America
    
      North America dominates the global full-body CT market, accounting for approximately 38% of worldwide revenue in 2024. The region's leadership stems from its advanced healthcare infrastructure, strong regulatory framework, and high adoption of innovative diagnostic imaging technologies. The United States contributes nearly 85% of regional market value, driven by widespread availability of CT scanners, increasing cancer screening programs, and growing demand for early disease detection. Both CT and PET-CT scanner adoption continues to rise, with major hospital networks increasingly investing in full-body imaging solutions for comprehensive diagnostic capabilities.
    
  </p><p>
  
    
      Technology leadership</p><p>
      The region leads in adopting AI-powered CT imaging solutions and low-dose scanning technologies, with FDA approvals accelerating commercial deployment. Major manufacturers actively collaborate with healthcare providers to develop customized full-body imaging protocols that reduce radiation exposure while maintaining diagnostic accuracy.
    
    
      Market concentration</p><p>
      Three-quarters of the regional installed base is concentrated across hospital systems and specialized diagnostic centers. Academic medical centers particularly drive demand for advanced full-body CT systems, utilizing them for both clinical applications and medical research studies involving large patient cohorts.
    
    
      Growth opportunities</p><p>
      Expanding applications in oncology, cardiovascular screening, and trauma care are creating new demand. The shift toward value-based healthcare and preventive medicine models is expected to sustain market growth, with compound annual growth projected at 5.8% through 2032.
    
    
      Market constraints</p><p>
      High equipment costs and stringent reimbursement policies limit adoption among smaller healthcare providers. Additionally, concerns about radiation exposure and the emergence of alternative imaging modalities present challenges that manufacturers must address through technological innovations.
    
  
</p><p>
</p><p><strong>Europe</strong></p><p>
Europe maintains the second-largest market share, with Germany, France, and the UK collectively representing over 60% of regional demand. The market benefits from well-established universal healthcare systems and progressive medical imaging policies, though adoption rates vary significantly between Western and Eastern European countries. Full-body CT utilization is increasing for comprehensive disease staging, particularly in oncology, but faces constraints from strict radiation safety guidelines that encourage judicious use. Market growth is being propelled by the replacement of aging CT systems with energy-efficient models featuring advanced dose-reduction technologies.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
Asia-Pacific demonstrates the highest growth potential, projected to expand at 7.2% CAGR through 2032, driven by healthcare infrastructure development in China and India. While Japan and South Korea lead in technology adoption with advanced imaging networks, emerging economies are experiencing rapid CT scanner deployment to address growing diagnostic needs. The region presents a dichotomy between premium hospitals investing in full-body imaging solutions and cost-conscious providers opting for conventional CT systems. Market expansion is further fueled by increasing medical tourism and government initiatives to modernize tertiary care facilities.</p><p>
</p><p><strong>South America</strong></p><p>
The South American market remains constrained by economic volatility and uneven healthcare access, though Brazil and Argentina account for the majority of full-body CT installations. Private healthcare networks and specialized diagnostic centers drive demand, while public sector adoption lags due to budget limitations. Market growth is gradually accelerating as multinational manufacturers expand local service networks and financing options become available for medium-sized medical facilities. However, the region faces persistent challenges including equipment maintenance issues and gaps in specialized radiology training.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
This region presents an emerging but fragmented market, with Gulf Cooperation Council countries accounting for over 70% of full-body CT installations. Major medical cities and specialty hospitals in Saudi Arabia and the UAE are early adopters, while other markets remain underserved. Import dependency and after-sales service limitations constrain market penetration, though increasing public-private partnerships in healthcare are creating new opportunities. The African market remains underdeveloped outside South Africa and Egypt, with infrastructure limitations and budget constraints significantly restricting full-body CT accessibility.</p><p></p><p><strong>Key Report Takeaways</strong></p><p></p><p>
</p><p>
</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Full-body CT, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Full-body CT companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Full-body CT Market?</strong></p><p>
</p><p><strong>-&gt;</strong> The global full-body CT market was valued at <strong>USD 2.84 billion in 2024</strong> and is expected to reach <strong>USD 5.67 billion by 2032</strong>.</p><p>
<strong>Which key companies operate in Global Full-body CT Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>GE Healthcare, Siemens Healthcare, Philips, Toshiba, Shimadzu, and Hitachi</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>increasing cancer screening programs, rising demand for early disease detection, and technological advancements in low-dose imaging</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; North America</strong> dominates the market, while <strong>Asia-Pacific</strong> is the fastest-growing region.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>spectral CT, photon-counting detectors, and AI-powered image reconstruction</strong>.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/124032/global-fullbody-ct-market">
            https://www.24chemicalresearch.com/reports/124032/global-fullbody-ct-market</a></b></div><br>
            <b>Table of Content:</b><p>Table of Content<br />
<br />
Chapter 1 Executive Summary<br />
<br />
Chapter 2 Abbreviation and Acronyms<br />
<br />
Chapter 3 Preface<br />
3.1 Research Scope<br />
3.2 Research Methodology<br />
  3.2.1 Primary Sources<br />
  3.2.2 Secondary Sources<br />
  3.2.3 Assumptions<br />
		<br />
Chapter 4 Market Landscape<br />
4.1 Market Overview<br />
4.2 Classification/Types<br />
4.3 Application/End Users<br />
<br />
Chapter 5 Market Trend Analysis <br />
5.1 Introduction<br />
5.2 Drivers<br />
5.3 Restraints<br />
5.4 Opportunities<br />
5.5 Threats<br />
<br />
Chapter 6 Industry Chain Analysis<br />
6.1 Upstream/Suppliers Analysis<br />
6.2 Full-body CT Analysis<br />
  6.2.1 Technology Analysis<br />
  6.2.2 Cost Analysis<br />
  6.2.3 Market Channel Analysis<br />
6.3 Downstream Buyers/End Users<br />
<br />
Chapter 7 Latest Market Dynamics<br />
7.1 Latest News<br />
7.2 Merger and Acquisition<br />
7.3 Planned/Future Project<br />
7.4 Policy Dynamics<br />
<br />
Chapter 8 Trading Analysis<br />
8.1 Export of Full-body CT by Region<br />
8.2 Import of Full-body CT by Region<br />
8.3 Balance of Trade<br />
<br />
Chapter 9 Historical and Current Full-body CT in North America (2016-2021)<br />
9.1 Full-body CT Supply <br />
9.2 Full-body CT Demand by End Use<br />
9.3 Competition by Players/Suppliers<br />
9.4 Type Segmentation and Price<br />
9.5 Key Countries Analysis<br />
  9.5.1 US<br />
  9.5.2 Canada<br />
  9.5.3 Mexico<br />
<br />
Chapter 10 Historical and Current Full-body CT in South America (2016-2021)<br />
10.1 Full-body CT Supply <br />
10.2 Full-body CT Demand by End Use<br />
10.3 Competition by Players/Suppliers<br />
10.4 Type Segmentation and Price<br />
10.5 Key Countries Analysis<br />
  10.5.1 Brazil<br />
  10.5.2 Argentina<br />
  10.5.3 Chile<br />
  10.5.4 Peru<br />
<br />
Chapter 11 Historical and Current Full-body C</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/124032/global-fullbody-ct-market">
            https://www.24chemicalresearch.com/reports/124032/global-fullbody-ct-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>